Agreement supports development and availability of an affordable, high-quality enzyme deficiency test SEATTLE, June 21, 2018 /PRNewswire/ -- PATH announced today a new partnership with South Korean ...

DNA can signal the presence of or predisposition to a slew of diseases, including cancer. The ability to flag down these clues, known as biomarkers, allows medical professionals to make critical early ...

This collaboration supports the advancement of the EpiCapture test, which is currently in late-stage development, to regulatory approval and commercialization. This initiative is part of Trinity ...

Biosensor company Sensortec and microfluidics specialist Minifab have announced that they are collaborating to provide a faster and lower cost microfluidic biosensor development platform for R&D ...

A clinical-stage diagnostics company using biosensors to develop tests that could cheaply and rapidly detect infectious diseases has raised $1.5 million. Using genetically engineered B cells — a type ...

Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Biosensor Market" report has been added to ResearchAndMarkets.com's offering. The global biosensor market accounted for USD 29.06 billion in 2023 ...

The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the world’s attention. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

WEST LAFAYETTE, Ind. - Researchers have created an ultrasensitive biosensor that could open up new opportunities for early detection of cancer and "personalized medicine" tailored to the specific ...

This device may enable miniaturization and new point-of-care applications in doctors' offices. Researchers have created an ultrasensitive biosensor that could open up new opportunities for early ...